Justin Wray

Title: Justin Wray: Innovator in Cancer Treatment

Introduction

Justin Wray is an accomplished inventor based in Albuquerque, NM (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic methods. His work focuses on enhancing the effectiveness of cancer treatments, particularly for patients suffering from leukemia.

Latest Patents

Justin Wray holds a patent for "Bifunctional metnase/intnase inhibitors and related compositions and methods of treatment of cancer." This invention relates to novel cancer treatment compositions and associated therapeutic methods. More specifically, it involves small chemical bifunctional inhibitors of DNA replication and repair proteins Metnase and/or Intnase that simultaneously damage DNA. The therapeutic method utilizes these inhibitors to improve the effectiveness of cancer treatment protocols, including radiation therapy. The compounds and methods are particularly beneficial for treating patients with acute myeloid leukemia (AML) and related cancers.

Career Highlights

Justin Wray is affiliated with the University of New Mexico, where he conducts his research and development. His work has led to advancements in cancer treatment methodologies, showcasing his commitment to improving patient outcomes. He has successfully developed a therapeutic approach that can be administered as a monotherapy or in combination with other anti-cancer agents.

Collaborations

Justin collaborates with notable colleagues, including Robert A Hromas and Andrei Leitao. Their combined expertise contributes to the innovative research being conducted at the University of New Mexico.

Conclusion

Justin Wray's contributions to cancer treatment through his patented inventions highlight the importance of innovation in medical research. His work not only advances scientific understanding but also offers hope for improved therapies for patients battling cancer.